Familial hypocalciuric hypercalcemia epidemiology and demographics: Difference between revisions

	Familial hypocalciuric hypercalcemia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Familial Hypocalciuric Hypercalcemia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Familial hypocalciuric hypercalcemia epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Familial hypocalciuric hypercalcemia epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Familial hypocalciuric hypercalcemia epidemiology and demographics
CDC on Familial hypocalciuric hypercalcemia epidemiology and demographics
Familial hypocalciuric hypercalcemia epidemiology and demographics in the news
Blogs on Familial hypocalciuric hypercalcemia epidemiology and demographics
Directions to Hospitals Treating Psoriasis
Risk calculators and risk factors for Familial hypocalciuric hypercalcemia epidemiology and demographics

VisualWikitext

Latest revision as of 14:34, 16 October 2017

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

There is insufficient evidence about the incidence of familial hypocalciuric hypercalcemia. The prevalence of FHH is estimated to be 0.78 in 100,000 hypercalcemia cases. Patients of all age groups may develop familial hypocalciuric hypercalcemia. There is neither racial or gender predisposition for familial hypocalciuric hypercalcemia.

Epidemiology and Demographics

Incidence

There is insufficient evidence about the incidence of familial hypocalciuric hypercalcemia.

Prevalence

The prevalence of FHH is estimated to be 0.78 in 100,000 hypercalcemia cases^[1].

Age

Patients of all age groups may develop familial hypocalciuric hypercalcemia.

Race

There is incomplete evidence regarding the racial predilection to familial hypocalciuric hypercalcemia.

Gender

Familial hypocalciuric hypercalcemia affects men and women equally.

References

↑ Hinnie J, Bell E, McKillop E, Gallacher S (2001). "The prevalence of familial hypocalciuric hypercalcemia". Calcif. Tissue Int. 68 (4): 216–8. doi:10.1007/s002230001201. PMID 11353947.

Template:WH Template:WS

[pmid11353947-1] Hinnie J, Bell E, McKillop E, Gallacher S (2001). "The prevalence of familial hypocalciuric hypercalcemia". Calcif. Tissue Int. 68 (4): 216–8. doi:10.1007/s002230001201. PMID 11353947.

[1]

@@ Line 4: / Line 4: @@
 {{CMG}}; {{AE}}
 ==Overview==
+There is insufficient evidence about the [[incidence]] of familial hypocalciuric hypercalcemia. The [[prevalence]] of [[FHH]] is estimated to be 0.78 in 100,000 [[hypercalcemia]] cases. Patients of all age groups may develop [[Familial hypocalciuric hypercalcemia|familial hypocalciuric hypercalcemia.]]  There is neither racial or gender predisposition for familial hypocalciuric hypercalcemia.
 ==Epidemiology and Demographics==
 ===Incidence===
-*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
+There is insufficient evidence about the [[incidence]] of familial hypocalciuric hypercalcemia.
-*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
 ===Prevalence===
-*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
+The [[prevalence]] of [[FHH]] is estimated to be 0.78 in 100,000 [[hypercalcemia]] cases<ref name="pmid11353947">{{cite journal |vauthors=Hinnie J, Bell E, McKillop E, Gallacher S |title=The prevalence of familial hypocalciuric hypercalcemia |journal=Calcif. Tissue Int. |volume=68 |issue=4 |pages=216–8 |year=2001 |pmid=11353947 |doi=10.1007/s002230001201 |url=}}</ref>.
-*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
-*The prevalence of [disease/malignancy] is estimated to be [number] cases annually.
-===Case-fatality rate===
-*In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate of [number range]%.
-*The case-fatality rate of [disease name] is approximately [number range].
 ===Age===
-*Patients of all age groups may develop [disease name].
+Patients of all age groups may develop [[Familial hypocalciuric hypercalcemia|familial hypocalciuric hypercalcemia.]]
-*The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
-*[Disease name] commonly affects individuals younger than/older than [number of years] years of age.
-*[Chronic disease name] is usually first diagnosed among [age group].
-*[Acute disease name] commonly affects [age group].
 ===Race===
-*There is no racial predilection to [disease name].
+There is incomplete evidence regarding the racial predilection to [[Familial hypocalciuric hypercalcemia|familial hypocalciuric hypercalcemia.]]
-*[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
 ===Gender===
-*[Disease name] affects men and women equally.
+[[Familial hypocalciuric hypercalcemia]] affects men and women equally.
-*[Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
-===Region===
-*The majority of [disease name] cases are reported in [geographical region].
-*[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
-===Developed Countries===
-===Developing Countries===
 ==References==